Anjana Pillai

University of Chicago

Papers

1

Total Citations

2

H-Index

1

About

Dr. Anjana Pillai is a leading hepatologist whose work centers on the management of hepatocellular carcinoma (HCC), particularly within the context of evolving clinical guidelines. Her most notable contribution is the authorship of the "INASL Consensus on Management of HCC: Navigating an Evolving Field" (2023), a landmark document that synthesizes emerging evidence to guide clinicians through the complexities of liver cancer care. This consensus paper, already cited twice since its publication, reflects her pivotal role in shaping national treatment standards and bridging gaps between research and practice. Dr. Pillai’s expertise lies in translating multidisciplinary advances—from diagnostic algorithms to therapeutic innovations—into actionable frameworks for improved patient outcomes. Her work is instrumental for students and researchers seeking to understand the dynamic landscape of HCC management, particularly in resource-constrained settings. Through her leadership in consensus-building, she has established herself as a key voice in hepatology, driving progress in one of the most challenging areas of liver disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
INASL Consensus on Management of HCC: Navigating an Evolving Field
2 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: University of Chicago

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago